Publication
Avoiding legal and regulatory pitfalls in digital transformation projects
This article first appeared in the September 2024 issue of Financier Worldwide.
United States | Publication | February 2022
Norton Rose Fulbright lawyers Roger Kuan and Jason Novak contributed several chapters to Digital Health 2022 International Comparative Legal Guide, published by GLG, which is a leading global platform for legal reference, analysis and news. Kuan also served as a contributing editor for the publication.
Authors: Roger Kuan, Norton Rose Fulbright and David Wallace, Johnson & Johnson
As an introduction into digital health, Kuan expands on the digital technologies in healthcare including healthcare IT, data use, data sharing, intellectual property, commercial agreements, AI and machine learning and liability and the acceleration transformation that was experienced during the pandemic.
Authors: Jason Novak, Norton Rose Fulbright and René Quashie, Consumer Technology Association
Novak explores Digital Therapeutics (DTx), an innovative subset of digital health that has quickly become a new platform for addressing treatment, management and prevention of various disease, as well as any legal and regulatory issues that may arise.
Authors: Roger Kuan and Jason Novak, Norton Rose Fulbright
In this chapter, Kuan and Novak provide answers to key questions regarding digital health and emerging technologies.
Publication
This article first appeared in the September 2024 issue of Financier Worldwide.
Publication
The Digital Markets, Competition and Consumers Act (DMCC Act) received Royal Assent on 24 May 2024 and is generally expected to come into force in autumn this year.
Publication
On 26 July 2024, the People’s Bank of China (PBOC) and the State Administration of Foreign Exchange (SAFE) jointly released revised rules in respect of the investments into China’s financial market through the Qualified Foreign Institutional Investor and Renminbi Qualified Foreign Institutional Investor (collectively, QFII) regime (the New Rules).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023